Revenue

The community-owned retailer gains institutional visibility with its Russell 3000 inclusion, but staggering losses and a volatile past paint a complex picture.

While game publishers chase players, a broken payment system siphons billions from their profits. A new report reveals the crisis and a stablecoin-based solution.

The digital age's biggest surprise isn't AI—it's the massive demand for electricians and welders. A new report reveals a skilled trades boom is here.

Futu Holdings faces a shareholder lawsuit after a $271M Chinese fine, highlighting the severe commercial risks of navigating regulatory gray areas abroad.

LightPath Technologies' Russell 3000 inclusion is no accident. It's a story of operational innovation and vertical integration in a critical sector.

The firm is on the cusp of controlling 5% of all ETH, a strategic accumulation that signals a new era of institutional power on the Ethereum network.

A new partnership brings AI surveillance to 700+ lots, promising enhanced safety but raising critical questions about privacy and public trust.

With its fibromyalgia drug now on the market, Tonix is expanding its use to MDD, targeting disturbed sleep in a novel approach for millions of patients.

Activist investor SilverCape issues a stark ultimatum to PetMed Express, cutting its takeover bid from $4 to $3, blaming board inaction for value destruction.

BioCryst is closing its discovery labs to save millions, betting on external partnerships for its next big drug. But what is the hidden cost of this pivot?

The AI-battery pioneer's inclusion in a major index brings institutional visibility, but a deep dive reveals a classic growth-versus-profitability story.

The AI revolution runs on electricity, but the grid can't keep up. A new class of company is emerging to fill the gap, turning power itself into the asset.

With CEO Steven Pelton’s immediate departure, Aegis Brands faces a critical juncture. Can an interim committee stabilize the ship amid declining revenues?

BPCL's new joint venture with Shell and Tiki Tar isn't just a deal—it's a strategic move to dominate India's high-value infrastructure materials market.

Despite a 24% income dip from lower oil prices, Mexco Energy’s debt-free strategy, rising gas output, and robust royalty income reveal a resilient playbook.

Digital signage firm Creative Realities plans a public offering to fund growth and fortify its balance sheet. Is this a signal of strength or a necessary risk?

Viridian's Lumvoa gains FDA approval for Thyroid Eye Disease, challenging a blockbuster drug and validating DRI Healthcare's unique royalty investment model.

Philip Morris International partners with Andrea Bocelli for a 'smoke-free' future. Is it a genuine transformation or a masterful act of reputation laundering?

Comcast's plan to split its media and tech arms is more than a corporate shuffle; it's a stark admission that the age of the all-in-one conglomerate is over.